Iodide

Iodide

SCHEMBL4157680

C=CC[N+]1(C)CCN(C(=O)Nc2cc(C)cc(C)c2)CC1.[I-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.45
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 3/20 0.42
GAA P10253 2/20 0.42
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
GOT1 P17174 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4154016 0.86 CACNA1H (0.41) ALDH1A1USP2
Iodide SCHEMBL4160958 0.86 MAPT (0.55) MAPTRAB9ANPC1ALDH1A1TSHR
Iodide SCHEMBL4150132 0.82 NPSR1 (0.56) MAPTRAB9ANPC1ALDH1A1GOT1
Iodide SCHEMBL4152051 0.82 MAPT (0.48) MAPTTHRBRAB9ANPC1ALDH1A1
Iodide SCHEMBL4173002 0.81 RAB9A (0.51) MAPTTHRBRAB9ANPC1ALDH1A1
Iodide SCHEMBL4159261 0.80 TRPV1 (0.49) MAPTTHRBRAB9AALDH1A1LMNA
Iodide SCHEMBL4159942 0.80 ALDH1A1 (0.58) MAPTRAB9ANPC1ALDH1A1LMNA
Iodide SCHEMBL4167966 0.80 ALDH1A1 (0.56) MAPTNPC1ALDH1A1LMNAUSP2
Iodide SCHEMBL4152999 0.77 ALDH1A1 (0.60) MAPTRAB9ANPC1ALDH1A1LMNA
Iodide SCHEMBL4162764 0.77 LMNA (0.48) MAPTTHRBRAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-05-07 US disclosed
US-7485646-B2 Serotonin 5-HT3 receptor agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2009-02-03 US disclosed
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2007-11-15 US disclosed
EP-1798227-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST Research Foundation Itsuu Laboratory (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118303-A1 SEROTONIN 5-HT3 RECEPTOR AGONIST HTR3A, HTR7, HTR1A MAPT 4268/4885THRB 281/4885RAB9A 849/4885
US-20070265277-A1 Serotonin 5-Ht3 Receptor Agonist HTR3A, HTR7, HTR1A MAPT 4268/4885THRB 281/4885RAB9A 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.